BIOLASE, Inc. (NASDAQ:BIOL – Get Free Report) was the recipient of a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 1,970,000 shares, a decrease of 6.2% from the May 31st total of 2,100,000 shares. Based on an average trading volume of 4,720,000 shares, the days-to-cover ratio is currently 0.4 days. Approximately 6.1% of the shares of the stock are short sold.
BIOLASE Stock Performance
Shares of NASDAQ BIOL opened at $0.10 on Thursday. BIOLASE has a fifty-two week low of $0.04 and a fifty-two week high of $10.31. The company’s 50 day simple moving average is $0.14 and its 200 day simple moving average is $0.38.
BIOLASE (NASDAQ:BIOL – Get Free Report) last issued its earnings results on Monday, May 13th. The medical technology company reported ($0.36) EPS for the quarter. The business had revenue of $10.13 million for the quarter. BIOLASE had a negative net margin of 43.56% and a negative return on equity of 1,782.73%.
Institutional Investors Weigh In On BIOLASE
Analyst Upgrades and Downgrades
Several research analysts have issued reports on the company. StockNews.com started coverage on BIOLASE in a report on Saturday, June 29th. They set a “sell” rating on the stock. Maxim Group lowered BIOLASE from a “strong-buy” rating to a “hold” rating in a research note on Friday, May 24th. Finally, Benchmark reiterated a “speculative buy” rating and issued a $0.40 price objective on shares of BIOLASE in a research report on Tuesday, May 14th.
Check Out Our Latest Analysis on BIOLASE
BIOLASE Company Profile
BIOLASE, Inc, together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications.
Read More
- Five stocks we like better than BIOLASE
- Trading Stocks: RSI and Why it’s Useful
- Celebrate July 4th with These Red, White, & Blue Chip Stocks
- What is the Euro STOXX 50 Index?
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Transportation Stocks Investing
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
Receive News & Ratings for BIOLASE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIOLASE and related companies with MarketBeat.com's FREE daily email newsletter.